B. Werneburg

发表

DNA polymerase beta: pre-steady-state kinetic analysis and roles of arginine-283 in catalysis and fidelity.

X. Zhong, B. Werneburg, J. Ahn, 1996, Biochemistry.

DNA Polymerase β: Structure−Fidelity Relationship from Pre-Steady-State Kinetic Analyses of All Possible Correct and Incorrect Base Pairs for Wild Type and R283A Mutant†

B. Werneburg, J. Ahn, M. Tsai, 1997 .

The discovery of carboline analogs as potent MAPKAP-K2 inhibitors.

Michel Emmanuel, Mohammed A Kashem, Lori Patnaude, 2007, Bioorganic & medicinal chemistry letters.

Pim kinase substrate identification and specificity.

B. Werneburg, N. Morrice, A. Knebel, 2006, Journal of biochemistry.

Catalysis and Function of the p38α·MK2a Signaling Complex

C. Pargellis, B. Werneburg, S. Lukas, 2004 .

Characterizing Treatment Utilization Patterns for Trigeminal Neuralgia in the United States

John Y. K. Lee, Y. Liu, B. Werneburg, 2018, The Clinical journal of pain.

Phenylmercuric acetate biodegradation by environmental strains of Pseudomonas species.

B. Werneburg, H. Monteil, I. Mirgain, 1989, Research in microbiology.

Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results

B. Werneburg, Deren Huang, R. Naismith, 2019, Multiple sclerosis journal - experimental, translational and clinical.

Synthesis and SAR studies of indole-based MK2 inhibitors.

M. Hao, C. Pargellis, B. Werneburg, 2008, Bioorganic & medicinal chemistry letters.

Pyrazinoindolone inhibitors of MAPKAP-K2.

M. Hao, R. Wasti, B. Werneburg, 2008, Bioorganic & medicinal chemistry letters.

Transfer of anti-HLA-DR antibodies from the mother to the child. Are DR antigens expressed on the placenta?

B. Werneburg, M. Tongio, S. Mayer, 2008, Tissue antigens.

DNA polymerase beta: effects of gapped DNA substrates on dNTP specificity, fidelity, processivity and conformational changes.

X. Zhong, B. Werneburg, J. Ahn, 1998, The Biochemical journal.

Effect of Zuranolone vs Placebo in Postpartum Depression

H. Gunduz-Bruce, Sigui Li, B. Werneburg, 2021, JAMA psychiatry.

Characterization of hypoactive sexual desire disorder (HSDD) in men.

L. Derogatis, I. Goldstein, B. Werneburg, 2012, The journal of sexual medicine.

Molecular Characterization of CD40 Signaling Intermediates*

B. Werneburg, M. Kehry, S. Zoog, 2001, The Journal of Biological Chemistry.

83 Biib059, a monoclonal antibody targeting bdca2, demonstrates evidence of proof of biological activity in subjects with cutaneous lupus

B. Werneburg, J. Merola, R. Furie, 2017, Lupus Science & Medicine.

COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta‐1a and subcutaneous interferon beta‐1a over 2 weeks in healthy subjects

I. Nestorov, K. Dawson, B. Werneburg, 2016, British journal of clinical pharmacology.

DNA polymerase beta: analysis of the contributions of tyrosine-271 and asparagine-279 to substrate specificity and fidelity of DNA replication by pre-steady-state kinetics.

X. Zhong, B. Werneburg, J. Ahn, 1997, The Biochemical journal.

Molecular basis of MAPK-activated protein kinase 2:p38 assembly

Bennett T. Farmer, B. Farmer, C. Pargellis, 2007, Proceedings of the National Academy of Sciences.

New serotypes of Pseudomonas cepacia.

B. Werneburg, H. Monteil, 1989, Research in microbiology.

Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder.

B. Werneburg, P. Hodgkins, K. O’Day, 2021, Journal of affective disorders.

Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice

R. Raijmakers, B. Werneburg, W. V. van Venrooij, 2006, The Journal of comparative neurology.

DNA Polymerase β: Multiple Conformational Changes in the Mechanism of Catalysis†

X. Zhong, B. Werneburg, M. Tsai, 1997 .

Subcutaneous peginterferon β-1a injection-site reaction experience and mitigation: Delphi analysis of the ALLOW study.

B. Werneburg, Deren Huang, R. Naismith, 2017, Neurodegenerative disease management.

DNA Polymerase β: Multiple Conformational Changes in the Mechanism of Catalysis†

X. Zhong, B. Werneburg, M. Tsai, 1997 .

Clostridium difficile toxin B: characterization and sequence of three peptides.

B. Werneburg, B. Rihn, G. Keith, 1989, Journal of chromatography.

Catalysis and function of the p38 alpha.MK2a signaling complex.

C. Pargellis, B. Werneburg, S. Lukas, 2004, Biochemistry.

The impact of early remission on disease trajectory and patient outcomes in major depression disorder (MDD): A targeted literature review and microsimulation modeling approach based on the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.

R. Kessler, B. Werneburg, M. Sussman, 2023, Journal of affective disorders.

Chemical modifications of chicken liver pyruvate carboxylase: evidence for essential cysteine-lysine pairs and a reactive sulfhydryl group.

B. Werneburg, D. Ash, 1993, Archives of biochemistry and biophysics.

Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder.

M. Kosinski, H. Gunduz-Bruce, B. Werneburg, 2022, Journal of affective disorders.

Discovery and characterization of a substrate selective p38alpha inhibitor.

C. Pargellis, B. Werneburg, S. Lukas, 2004, Biochemistry.

Structural and biochemical analysis of signal transduction by the TRAF family of adapter proteins.

T. Alber, B. Werneburg, M. Kehry, 1999, Cold Spring Harbor symposia on quantitative biology.

ORIGINAL RESEARCH—MEN'S SEXUAL HEALTH Characterization of Hypoactive Sexual Desire Disorder (HSDD)

L. Derogatis, I. Goldstein, B. Werneburg, 2012 .

DNA polymerase β : effects of gapped DNA substrates on dNTP specificity, fidelity, processivity and conformational changes1

X. Zhong, B. Werneburg, V. Kraynov, 1998 .

SAT0222 BIIB059, a monoclonal antibody targeting BDCA2, shows evidence of biological activity and early clinical proof of concept in subjects with active cutaneous le

B. Werneburg, J. Merola, L. Stevenson, 2017 .

Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review.

B. Werneburg, K. Duckworth, I. Aleksanderek, 2022, The Journal of clinical psychiatry.

Impact of Treating Depression on Associated Comorbidities: A Systematic Literature Review.

B. Werneburg, K. Duckworth, I. Aleksanderek, 2023, The primary care companion for CNS disorders.